These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 25038718)
21. Role of endorectal prostate MRI in patients with initial suspicion of prostate cancer. Franiel T; Vargas HA; Mazaheri Y; Böhmer S; Hricak H; Akin O; Beyersdorff D Rofo; 2013 Oct; 185(10):967-74. PubMed ID: 24490232 [TBL] [Abstract][Full Text] [Related]
22. Localizing prostate cancer in the presence of postbiopsy changes on MR images: role of proton MR spectroscopic imaging. Kaji Y; Kurhanewicz J; Hricak H; Sokolov DL; Huang LR; Nelson SJ; Vigneron DB Radiology; 1998 Mar; 206(3):785-90. PubMed ID: 9494502 [TBL] [Abstract][Full Text] [Related]
23. Inter-reader agreement of multi-parametric MR imaging for the detection of prostate cancer: evaluation of a scoring system. Quentin M; Arsov C; Röhlen S; Klasen J; Antoch G; Albers P; Blondin D Rofo; 2012 Oct; 184(10):925-9. PubMed ID: 22744328 [TBL] [Abstract][Full Text] [Related]
24. High diagnostic ability of multiparametric magnetic resonance imaging to detect anterior prostate cancer missed by transrectal 12-core biopsy. Komai Y; Numao N; Yoshida S; Matsuoka Y; Nakanishi Y; Ishii C; Koga F; Saito K; Masuda H; Fujii Y; Kawakami S; Kihara K J Urol; 2013 Sep; 190(3):867-73. PubMed ID: 23542406 [TBL] [Abstract][Full Text] [Related]
25. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings. Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768 [TBL] [Abstract][Full Text] [Related]
26. Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis. Tamada T; Sone T; Jo Y; Yamamoto A; Yamashita T; Egashira N; Imai S; Fukunaga M Radiology; 2008 Aug; 248(2):531-9. PubMed ID: 18539890 [TBL] [Abstract][Full Text] [Related]
27. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined. Chen M; Dang HD; Wang JY; Zhou C; Li SY; Wang WC; Zhao WF; Yang ZH; Zhong CY; Li GZ Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549 [TBL] [Abstract][Full Text] [Related]
28. MR imaging of the prostate at 3.0T with external phased array coil - preliminary results. Morakkabati-Spitz N; Bastian PJ; Gieseke J; Träber F; Kuhl CK; Wattjes MP; Müller SC; Schild HH Eur J Med Res; 2008 Jun; 13(6):287-91. PubMed ID: 18558555 [TBL] [Abstract][Full Text] [Related]
29. 3.0 T multiparametric prostate MRI using pelvic phased-array coil: utility for tumor detection prior to biopsy. Rosenkrantz AB; Mussi TC; Borofsky MS; Scionti SS; Grasso M; Taneja SS Urol Oncol; 2013 Nov; 31(8):1430-5. PubMed ID: 22464245 [TBL] [Abstract][Full Text] [Related]
30. Standardized threshold approach using three-dimensional proton magnetic resonance spectroscopic imaging in prostate cancer localization of the entire prostate. Fütterer JJ; Scheenen TW; Heijmink SW; Huisman HJ; Hulsbergen-Van de Kaa CA; Witjes JA; Heerschap A; Barentsz JO Invest Radiol; 2007 Feb; 42(2):116-22. PubMed ID: 17220729 [TBL] [Abstract][Full Text] [Related]
31. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. Kurhanewicz J; Vigneron DB; Hricak H; Narayan P; Carroll P; Nelson SJ Radiology; 1996 Mar; 198(3):795-805. PubMed ID: 8628874 [TBL] [Abstract][Full Text] [Related]
32. Prostate cancer in magnetic resonance imaging: diagnostic utilities of spectroscopic sequences. Caivano R; Cirillo P; Balestra A; Lotumolo A; Fortunato G; Macarini L; Zandolino A; Vita G; Cammarota A J Med Imaging Radiat Oncol; 2012 Dec; 56(6):606-16. PubMed ID: 23210579 [TBL] [Abstract][Full Text] [Related]
33. Prostate cancer: feasibility and preliminary experience of a diffusional kurtosis model for detection and assessment of aggressiveness of peripheral zone cancer. Rosenkrantz AB; Sigmund EE; Johnson G; Babb JS; Mussi TC; Melamed J; Taneja SS; Lee VS; Jensen JH Radiology; 2012 Jul; 264(1):126-35. PubMed ID: 22550312 [TBL] [Abstract][Full Text] [Related]
34. MR-guided prostate biopsy for planning of focal salvage after radiation therapy. Ménard C; Iupati D; Publicover J; Lee J; Abed J; O'Leary G; Simeonov A; Foltz WD; Milosevic M; Catton C; Morton G; Bristow R; Bayley A; Atenafu EG; Evans AJ; Jaffray DA; Chung P; Brock KK; Haider MA Radiology; 2015 Jan; 274(1):181-91. PubMed ID: 25203127 [TBL] [Abstract][Full Text] [Related]
35. Magnetic resonance imaging-directed transperineal limited-mapping prostatic biopsies to diagnose prostate cancer: a Scottish experience. Mukherjee A; Morton S; Fraser S; Salmond J; Baxter G; Leung HY Scott Med J; 2014 Nov; 59(4):204-8. PubMed ID: 25314954 [TBL] [Abstract][Full Text] [Related]
36. 1.5-T multiparametric MRI using PI-RADS: a region by region analysis to localize the index-tumor of prostate cancer in patients undergoing prostatectomy. Reisæter LA; Fütterer JJ; Halvorsen OJ; Nygård Y; Biermann M; Andersen E; Gravdal K; Haukaas S; Monssen JA; Huisman HJ; Akslen LA; Beisland C; Rørvik J Acta Radiol; 2015 Apr; 56(4):500-11. PubMed ID: 24819231 [TBL] [Abstract][Full Text] [Related]
37. Differentiation of transitional zone prostate cancer from benign hyperplasia nodules: evaluation of discriminant criteria at multiparametric MRI. Chesnais AL; Niaf E; Bratan F; Mège-Lechevallier F; Roche S; Rabilloud M; Colombel M; Rouvière O Clin Radiol; 2013 Jun; 68(6):e323-30. PubMed ID: 23528164 [TBL] [Abstract][Full Text] [Related]
38. [Staging of prostate cancer: value of the combined information of endorectal MRI, biopsy Gleason score, and preoperative PSA level]. Wetter A; Ajdukovic AN; Fliessbach K; Lehnert T; Engl T; Jacobi V; Vogl TJ Rofo; 2006 Apr; 178(4):385-90. PubMed ID: 16607587 [TBL] [Abstract][Full Text] [Related]
39. 3-T in-bore MR-guided prostate biopsy based on a scoring system for target lesions characterization. Quentin M; Schimmöller L; Arsov C; Rabenalt R; Antoch G; Albers P; Blondin D Acta Radiol; 2013 Dec; 54(10):1224-9. PubMed ID: 23878360 [TBL] [Abstract][Full Text] [Related]
40. Non-invasive estimation of prostate cancer aggressiveness using diffusion-weighted MRI and 3D proton MR spectroscopy at 3.0 T. Thörmer G; Otto J; Horn LC; Garnov N; Do M; Franz T; Stolzenburg JU; Moche M; Kahn T; Busse H Acta Radiol; 2015 Jan; 56(1):121-8. PubMed ID: 24504488 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]